These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427 [TBL] [Abstract][Full Text] [Related]
4. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Can A; Coskun H Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878 [TBL] [Abstract][Full Text] [Related]
5. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome. Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM Cells; 2020 Sep; 9(9):. PubMed ID: 32887260 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Harrell CR; Jovicic BP; Djonov V; Volarevic V Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential. Xiong J; Bao L; Qi H; Feng Z; Shi Y Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246 [TBL] [Abstract][Full Text] [Related]
8. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19. Gu J; Zhao Q; Han Z; Han Z Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428 [TBL] [Abstract][Full Text] [Related]
9. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS. Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L Front Immunol; 2021; 12():738697. PubMed ID: 34659231 [TBL] [Abstract][Full Text] [Related]
10. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? Hamdan H; Hashmi SK; Lazarus H; Gale RP; Qu W; El Fakih R Blood Rev; 2021 Mar; 46():100742. PubMed ID: 32854985 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Loke XY; Imran SAM; Tye GJ; Wan Kamarul Zaman WS; Nordin F Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830303 [TBL] [Abstract][Full Text] [Related]
12. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19. Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079 [TBL] [Abstract][Full Text] [Related]
13. Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock? Laroye C; Gibot S; Reppel L; Bensoussan D Stem Cells; 2017 Dec; 35(12):2331-2339. PubMed ID: 28856759 [TBL] [Abstract][Full Text] [Related]
14. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19. Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081 [TBL] [Abstract][Full Text] [Related]
15. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911 [TBL] [Abstract][Full Text] [Related]
16. Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS. Aitong W; Leisheng Z; Hao Y Curr Stem Cell Res Ther; 2022; 17(1):2-12. PubMed ID: 34254927 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review. Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652 [TBL] [Abstract][Full Text] [Related]
18. Recent progress in mesenchymal stem cell-based therapy for acute lung injury. Liang J; Dai W; Xue S; Wu F; Cui E; Pan R Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19. Xiong J; Chen L; Zhang L; Bao L; Shi Y Cell Transplant; 2021; 30():963689721995455. PubMed ID: 33650894 [TBL] [Abstract][Full Text] [Related]
20. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential. Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]